Medication reconciliation is an important aspect of a patientâ??s care process that is\nideally performed by clinical pharmacists. Despite literature supporting this process in other\npatient populations, cystic fibrosis (CF) lacks research in this area. To address this, we designed a\nretrospective, multi-centered, non-controlled, cross-sectional study at four CF Foundation-accredited\ncenters in the United States to evaluate the medication reconciliation process for adult and pediatric\nCF patients by documenting the number of home medications reconciled by clinical pharmacists\nand the number of patients with home medications that did not align with the current CF guidelines\npublished in 2013. There were 105 adult patients and 72 pediatric patients included in the study\nanalysis with a mean number of medications reconciled by clinical pharmacists of 17.4 (standard\ndeviation (SD) 6.7) for adults and 13 (SD 4.6) for pediatric patients. The mean number of discrepancies\nfrom guidelines per patient was 1.61 (SD 1.2) for adult patients and 0.63 (SD 0.9) for pediatric patients.\nPharmacists play an essential role in identifying and managing medication interactions and further\nresearch is necessary to investigate pharmacist impact on medication reconciliation.
Loading....